Latest Pharma Insights
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases...
Pink Sheet - March 29, 2024
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases...
Pink Sheet - March 29, 2024
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons...
Scrip - March 28, 2024
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons...
Scrip - March 28, 2024
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I...
Scrip - March 28, 2024
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I...
Scrip - March 28, 2024
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate...
Scrip - March 28, 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate...
Scrip - March 28, 2024
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at...
Scrip - March 28, 2024
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at...
Scrip - March 28, 2024
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A...
Scrip - March 28, 2024
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A...
Scrip - March 28, 2024
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases...
Pink Sheet - March 29, 2024
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases...
Pink Sheet - March 29, 2024
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint...
Medtech Insight - March 28, 2024
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint...
Medtech Insight - March 28, 2024
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall...
Medtech Insight - March 28, 2024
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall...
Medtech Insight - March 28, 2024
EU Must Crack Down Harder On Fake Medical Devices, Says Innovator
Counterfeit copies of LifeVac Europe’s anti-choking devices have been registered on the EU’s EUDAMED database and continue to be sold...
Medtech Insight - March 28, 2024
Counterfeit copies of LifeVac Europe’s anti-choking devices have been registered on the EU’s EUDAMED database and continue to be sold...
Medtech Insight - March 28, 2024
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in...
HBW Insight - March 28, 2024
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in...
HBW Insight - March 28, 2024
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards...
HBW Insight - March 28, 2024
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards...
HBW Insight - March 28, 2024
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm...
HBW Insight - March 28, 2024
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm...
HBW Insight - March 28, 2024
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste...
HBW Insight - March 28, 2024
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste...
HBW Insight - March 28, 2024
Medicines For Europe Responds To New EU Biotech Initiative
The European off-patent drug organization offered a few suggestions to the European Commission’s unveiled Biotech initiative and its key steps...
Generics Bulletin - March 27, 2024
The European off-patent drug organization offered a few suggestions to the European Commission’s unveiled Biotech initiative and its key steps...
Generics Bulletin - March 27, 2024
Henlius Reports First Fully Profitable Year After Past Losses
After reporting losses for the past two years, the Chinese pharma announced the first full year of profitability on the...
Generics Bulletin - March 27, 2024
After reporting losses for the past two years, the Chinese pharma announced the first full year of profitability on the...
Generics Bulletin - March 27, 2024
India IPR Realities: Pharma, Legal Heads Discuss Winds Of Change, ‘Damocles Sword’
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Generics Bulletin - March 27, 2024
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving...
Generics Bulletin - March 27, 2024
Open For Business: Sandoz’s Austrian Antibiotic Facility Is Ready To Serve
As Sandoz continues to fight against antimicrobial resistance, the firm opens a new production facility in Austria, strengthening its position...
Generics Bulletin - March 27, 2024
As Sandoz continues to fight against antimicrobial resistance, the firm opens a new production facility in Austria, strengthening its position...
Generics Bulletin - March 27, 2024
J&J Refines Direction For Ottava
Delays have plagued J&J's soft tissue surgical robot. However, the company has now solidified at least its near-term plan and...
In Vivo - March 26, 2024
Delays have plagued J&J's soft tissue surgical robot. However, the company has now solidified at least its near-term plan and...
In Vivo - March 26, 2024